文献速递肝胆胰外科胃肠外科

胰腺切除联合结肠切除的适应证:何时安全?

Indication for en bloc pancreatectomy with colectomy: when is it safe?
PubMed 文献 · Surg Endosc · 2017-06-29

该研究基于单中心前瞻性数据库,比较胰腺切除联合结肠切除(P+C)与单纯胰腺切除(P)的发病率与死亡率。P+C占胰腺切除的2.39%,其30天和90天发病率及死亡率均显著高于P,结肠切除是90天死亡的独立危险因素。

要点

  • P+C的30天发病率54% vs 37%、死亡率9% vs 2%,均显著高于P。
  • P+C的90天发病率61% vs 42%、死亡率14% vs 3%,均显著高于P。
  • 结肠切除是90天死亡的独立危险因素(p=0.013,OR=3.556)。

核心结论

  • 胰腺切除联合结肠切除显著增加发病率与死亡率,结肠切除是90天死亡的独立危险因素。

主要发现

  • P+C占全部胰腺切除的2.39%(43/1797),其中胰十二指肠切除术占61%(26例)、远端胰腺切除占37%(16例)、全胰腺切除占2%(1例)。
  • P+C的30天发病率54% vs P的37%(p=0.037),30天死亡率9% vs 2%(p=0.022)。
  • P+C的90天发病率61% vs P的42%(p=0.019),90天死亡率14% vs 3%(p=0.002)。
  • 逻辑回归显示90天死亡率与结肠切除相关(p=0.013,OR=3.556)。
  • 亚组分析显示胰腺切除类型、原发病灶来源、手术指征(恶性 vs 非恶性)或计划状态(计划性 vs 术中决定)均无显著差异。

临床怎么用

  • 应向患者告知胰腺切除联合结肠切除术后并发症和死亡风险增加。
  • 在进一步研究识别可用于风险分层的患者或围术期因素之前,应谨慎选择P+C。

局限性

  • 单中心回顾性分析,样本量较小(P+C仅43例),结论需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Aggressive en bloc resection of adjacent organs is often necessary to resect pancreatic or colonic lesions. However, it is debated whether simultaneous pancreatectomy with colectomy (P+C) is warranted as it potentially increases morbidity and mortality (MM). We hypothesized that MM would be increased in P+C, especially in cases of pancreatitis. METHODS: All patients who underwent pancreatectomy (P) and simultaneous pancreatectomy with colectomy (P+C) at a high-volume center from November 2006 to 2015 were prospectively collected using ACS-NSQIP at our institution. Patients with additional multivisceral or enucleation procedures were excluded. Data were augmented to 90-day outcomes using our institutional database. RESULTS: Forty-three patients with a mean age of 62 years (27:16 male: female) underwent P+C, accounting for 2.39% (43/1797) of pancreatectomies performed. Pancreatoduodenectomy (PD) was performed in 61% (n = 26), distal pancreatectomy (DP) in 37% (n = 16), and total pancreatectomy (TP) in 2% (n = 1) of patients. The 30- and 90-day MM were higher in P+C than P (30-day: 54 vs. 37%, p = 0.037 and 9 vs. 2%, p = 0.022; 90-day: 61 vs. 42%, p = 0.019 and 14 vs. 3%, p = 0.002). Logistical regression modeling revealed an association between 90-day mortality and colectomy (p = 0.013, OR = 3.556). When P+C MM were analyzed according to intraoperative factors, there was no significant difference according to type of pancreatectomy (PD vs. DP vs. TP), origin of primary lesion (pancreas vs. colon), surgical indication (malignant vs. non-malignant), or case status (planned colectomy vs. intraoperative decision). CONCLUSIONS: Addition of colectomy to pancreatectomy substantially increased MM. Subanalysis revealed that type of resection performed, etiology, and planning status did not account for increased risk when performing P+C. However, colectomy was found to be an independent risk factor for mortality. Therefore, patients should be informed of the risk of increased postoperative complications until a further study can identify potential patients or perioperative factors that can be used for risk stratification.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Schwartz PB, Roch AM, Han JS, et al. Indication for en bloc pancreatectomy with colectomy: when is it safe? Surg Endosc. 2017. PMID: 28664444. doi:10.1007/s00464-017-5700-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。